Related Experiment Video
Updated: Oct 28, 2026

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Nancy Histological Index and endoscopic activity, clinical activity, and disease extent in pediatric ulcerative
Ayrin Sheikholeslami1, Maryam Vajihinejad1, Roohollah Edalatkhah2,3
1Department of Pathology, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Objectives:
Data on relationships among disease assessment domains in pediatric ulcerative colitis (UC) remain limited. This study evaluated associations between histopathologic activity assessed by the Nancy Index (NI), endoscopic activity assessed by the Mayo Endoscopic Subscore (MES), clinical activity assessed by the Partial Mayo Score (PMS), and Montréal-classified disease extent in children with UC.
Methods:
This retrospective cross-sectional study included UC patients aged 1-16 years who underwent colonoscopy with biopsy and had paired data from the same disease assessment episode. Associations were examined using multivariable logistic regression models.
Results:
In age- and sex-adjusted models, increasing NI grades showed a significant dose-response association with MES: NI = 2 (odds ratio [OR]: 26.67, 95% confidence interval [CI] [1.83; 388.15]; p = 0.016), NI = 3 (OR: 83.29, 95% CI [5.37; 1290.84]; p = 0.002), and NI = 4 (OR: 191.71, 95% CI [11.34; 3241.88]; p < 0.001). Higher NI grades also showed a graded association with PMS, particularly NI = 3 (OR: 31.84, 95% CI [2.78; 365.12]; p = 0.005) and NI = 4 (OR: 53.56, 95% CI [4.77; 600.81]; p = 0.001). Each one-grade increase in NI was significantly associated with greater disease extent (OR: 1.55, 95% CI: [1.10; 2.18]; p = 0.012).
Conclusion:
Increasing histopathologic activity of UC in pediatric patients showed a strong dose-response association for endoscopic activity and, to a lesser extent, with clinical activity and disease extent. These findings suggest that histopathologic activity reflects multiple disease domains in pediatric UC and may have predictive value.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
